Quantum BioPharma Ltd C.QNTM

JUSTFACTS!

[Chuckie18]

In order to evaluate its existing profitability and to better understand the uncertainties and costs inherent in designing, tracking and assessing appropriate budgets, the organization is now evaluating its latest phase 2 trial.

[Chuckie18]

Implementing a solid structure of corporate and financial management that limits administrators and managers to pay themselves over industry levels

[Chuckie18]

In February 2021 the board of directors awarded a disproportionate amount in total of approximately $6.6 million worth FSD's market value for the company, in acknowledgment of its loss and in particular Dr Bokhari (as at the closing price of February 10, 2021). The Board of Directors (excluding shareholders concerned) permitted Dr. Bokhari to take free legal action and threaten two of the

[Chuckie18]

This diluent share issue occurs at a time when the stock price of the class B share is low and short-term expense is absolutely unavoidable for financing. In order to make the most of the issuing of Class B shares by the Company, Dr. Bokhari and the Board of Directors (other than Mr. Durkagz and Mr. Saeed) do little to control the capital raise process of the Company. In his own words, he said,

[Chuckie18]

On January 3, 2021 MMs. Durkacz and Saeed addressed the company's continued decline while the Chief Executive Officer and other members of the Board were deliberately obstructing, following members of the Executive Director, who did not attend both the December 22 Board of Management Meetings and December 30 Board Meeting. In order to replace management other than Ms Durkacz and Saeed with new

[Chuckie18]

Bokhari has failed to effectively implement the corporate plan and has not been able to meet any smaller goals recorded to date.

[Chuckie18]

Bokhari has led FSD to refund Dr. Bokhari's private sector to manage more than USD $1.4 million in 2020. With no responsibility or explanation.

[Chuckie18]

In February 2021 Bokhari granted the other managers of Stephen Buyer, Robert Ciaruffoli, James Datin, Gerold Goldberg and Larry Kaiser over $5.7 million in incentive shares payments for services yet to be provided and almost 1 million dollars in share and assets, about double the amount of years before.

[Chuckie18]

Bokhari has massively reduced shareholders' confidence by selling almost 16 million shares at low prices and thereby increasing the remaining 83 percent in just seven weeks.

[Chuckie18]

Raza Bokhari has fought for the dramatic reduction of shareholder equity, moving more than 97 percent less than when Dr Bokhari was elected interim CEO;

[Mil_Man54]

Oh look....realization is using one of his older pumper accounts to post this morning

[mhaimillionaire]

Following the failure of Board members to attend both the December 22 Board Meeting and the December 30 Board Meeting, Messrs. Durkacz and Saeed spoke with the other Concerned Shareholders on January 3, 2021 about the Company’s continuing decline in the face of the active obstruction of the Chief Executive Officer and other Board members.